04/21/2020 / By Ethan Huff
An unusual strain of coronavirus that was isolated in India has been found to contain a strange mutation that experts warn could completely derail all efforts to develop a vaccine for the Wuhan coronavirus (COVID-19) at large.
Researchers from both Australia and Taiwan are warning that this mutated strain of coronavirus follows a much different pathway when it comes to causing infection in the form of severe acute respiratory syndrome (SARS). Simply put, a vaccine for the coronavirus strain currently in mass circulation probably wouldn’t work for this other strain, or any other mutated strain for that matter.
The change in this mutated strain occurred in part of the spike protein that normally allows the Wuhan coronavirus (COVID-19) to bind with certain human cells. This protein specifically targets cells containing ACE2, an enzyme found in the outer surface cells of the lungs.
By targeting this enzyme, said protein allows the SARS virus to infect people with illness, which is why vaccine researchers have been rushing to come up with antibodies that might target it. But the mutation identified in this other strain of coronavirus means that a whole different approach would be necessary to stop it from causing infection.
“The observation of this study raised the alarm that Sars-CoV-2 mutation that varied epitope (something that an antibody attaches itself to) profile could arise at any time,” wrote the team of collaborators from Murdoch University in Australia and the National Changhua University of Education in Taiwan.
“This means current vaccine development against Sars-CoV-2 is at great risk of becoming futile.”
Be sure to listen below to The Health Ranger Report as Mike Adams, the Health Ranger, takes a closer look at how food riots are likely to ignite if the Wuhan coronavirus (COVID-19) lockdowns aren’t ended by May:
What’s further perplexing about the situation is the fact that it took two months for the full gene sequence of this mutated coronavirus strain to be released by the National Institute of Virology, which received it a while back after it was collected from a patient in Kerala.
Why it took this Indian government agency so long to release it has created more questions than there are answers as to just how serious this situation truly is. Even more concerning is a warning put out by the South China Morning Post, admittedly a communist Chinese government propaganda outlet, that there’s much more to come in the area of mutations.
“[T]here is real concern growing that thousands of strains sampled and sequenced are just the tip of the iceberg – and great variety increases the risk that new strains will require new vaccines in the same way the flu virus does,” the paper reported.
Even so, the race is on to release one, two, or even seven, in the case of billionaire eugenicist Bill Gates, different vaccines for the Wuhan coronavirus (COVID-19) as quickly as possible. Globalists everywhere are insisting that everyone be vaccinated with one or all of them in order to ever again be allowed to live a normal life as part of a functioning society.
“There is no vaccine for any type of flu,” pointed out one Fox News commenter about how this whole push for a coronavirus vaccine was futile from the start.
“You can get a flu shot which helps your body produce the necessary antibodies to fight certain strains, but it does not vaccinate you against the flu. There was and is no such vaccine for SARS, MERS, etc.”
More of the latest news about the Wuhan coronavirus (COVID-19) is available at Pandemic.news.
Sources for this article include:
Tagged Under: China, Chinese Virus, coronavirus, coronavirus vaccine, covid-19, disease, global emergency, Global Pandemic, immunity, India, infection, mutation, mutations, novel coronavirus, outbreak, pandemic, SARS, SARS-CoV-2, vaccine, vaccines, virus, Wuhan, Wuhan coronavirus
Vaccines.News is a fact-based public education website published by Vaccines News Features, LLC.
All content copyright © 2018 by Vaccines News Features, LLC.
Contact Us with Tips or Corrections
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.